A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus

Published:2021-09 Issue:3 Volume:103 Page:135-142
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Yamagami Jun,Ujiie Hideyuki,Aoyama Yumi,Ishii Norito,Tateishi Chiharu,Ishiko Akira,Ichijima Tomoki,Hagihara Shunsuke,Hashimoto Koji,Amagai Masayuki

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference28 articles.

1. Pemphigus;Kasperkiewicz;Nat. Rev. Dis. Primers,2017

2. Pemphigus;Amagai,2017

3. Autoimmune bullous skin diseases, pemphigus and pemphigoid;Egami;J. Allergy Clin. Immunol.,2020

4. Pemphigus: current and future therapeutic strategies;Didona;Front. Immunol.,2019

5. Pemphigus;Schmidt;Lancet,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Bruton’s tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments;Advances in Rheumatology;2024-08-21

2. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

3. What is novel in the clinical management of pemphigus vulgaris?;Expert Review of Clinical Pharmacology;2024-05-12

4. Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia;Current Hematologic Malignancy Reports;2024-03-27

5. Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective;Heliyon;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3